Global Classical Swine Fever Vaccines Competitive Landscape Professional Research Report 2026

According to DIResearch＇s in-depth investigation and research, the global Classical Swine Fever Vaccines market size will reach 191.93 Million USD in 2026 and is projected to reach 266.66 Million USD by 2033, with a CAGR of 4.81% (2026-2033). Notably, the China Classical Swine Fever Vaccines market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Classical swine fever vaccines are vaccines developed to protect pigs from classical swine fever (CSF), also known as hog cholera. CSF is a highly contagious viral disease that affects domestic and wild pigs, causing significant economic losses in the swine industry. The vaccines are designed to stimulate the pig＇s immune system to produce protective antibodies against the CSF virus, preventing infection and reducing the severity of the disease if exposure occurs. Classical swine fever vaccines can be divided into two main categories: live attenuated vaccines and inactivated vaccines. Live attenuated vaccines contain weakened forms of the CSF virus, while inactivated vaccines contain killed virus particles. Both types of vaccines have proven effective in controlling and preventing the spread of the disease. Vaccination is a crucial tool in CSF control and eradication programs, especially in areas where the disease is endemic or in situations where outbreaks occur. Proper vaccination protocols, biosecurity measures, and surveillance are essential components of a comprehensive strategy to protect swine herds and ensure the health and productivity of the pig industry.

The major global suppliers of Classical Swine Fever Vaccines include Winsun Bio-Pharmaceutical, MSD Animal Health, CAHIC, Tecon, SPAH, Boehringer Ingelheim, Ceva, Harbin Weike BIOTECHNOLOGY, Qilu Animal Health Products, Ringpu Bio-Technology, DaHuaNong Animal Health Products, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, Institutul Pasteur, MVP, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Classical Swine Fever Vaccines. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Classical Swine Fever Vaccines market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Classical Swine Fever Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Classical Swine Fever Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Classical Swine Fever Vaccines Include:

Winsun Bio-Pharmaceutical

MSD Animal Health

CAHIC

Tecon

SPAH

Boehringer Ingelheim

Ceva

Harbin Weike BIOTECHNOLOGY

Qilu Animal Health Products

Ringpu Bio-Technology

DaHuaNong Animal Health Products

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Institutul Pasteur

MVP

Classical Swine Fever Vaccines Product Segment Include:

C-Strain Live Attenuated Vaccine

Thiverval Strain Vaccine

Others

Classical Swine Fever Vaccines Product Application Include:

Government Tender

Market Sales

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Classical Swine Fever Vaccines Industry PESTEL Analysis

Chapter 3: Global Classical Swine Fever Vaccines Industry Porter’s Five Forces Analysis

Chapter 4: Global Classical Swine Fever Vaccines Major Regional Market Size and Forecast Analysis

Chapter 5: Global Classical Swine Fever Vaccines Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Classical Swine Fever Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Classical Swine Fever Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Classical Swine Fever Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Classical Swine Fever Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Classical Swine Fever Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Classical Swine Fever Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Classical Swine Fever Vaccines Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table 1： Global Classical Swine Fever Vaccines Market Size Growth Rate by Type, 2025 VS 2026 VS 2033 (US$ Million)

Table 2： Global Classical Swine Fever Vaccines Market Size Growth Rate by Application, 2025 VS 2026 VS 2033 (US$ Million)

Table 3： Classical Swine Fever Vaccines Industry Development Status

Table 4： Classical Swine Fever Vaccines Industry Development Trends

Table 5： Global Classical Swine Fever Vaccines Market Size by Region in US$ Million: 2025 VS 2026 VS 2033

Table 6： Global Classical Swine Fever Vaccines Revenue by Region (2021-2026) & (US$ Million)

Table 7： Global Classical Swine Fever Vaccines Revenue Market Share by Region (2021-2026)

Table 8： Global Classical Swine Fever Vaccines Revenue Forecast by Region (2027-2033) & (US$ Million)

Table 9： Global Classical Swine Fever Vaccines Revenue Market Share Forecast by Region (2027-2033)

Table 10： Global Classical Swine Fever Vaccines Revenue Analysis by Type (2021-2026) & (US$ Million)

Table 11： Global Classical Swine Fever Vaccines Revenue Analysis Forecast by Type (2027-2033) & (US$ Million)

Table 12： Global Classical Swine Fever Vaccines Revenue Analysis by Application (2021-2026) & (US$ Million)

Table 13： Global Classical Swine Fever Vaccines Revenue Analysis Forecast by Application (2027-2033) & (US$ Million)

Table 14： Key Classical Swine Fever Vaccines Players in North America

Table 15： North America Classical Swine Fever Vaccines Revenue by Type (2021-2026) & (US$ Million)

Table 16： North America Classical Swine Fever Vaccines Revenue by Type (2027-2033) & (US$ Million)

Table 17： North America Classical Swine Fever Vaccines Revenue by Application (2021-2026) & (US$ Million)

Table 18： North America Classical Swine Fever Vaccines Revenue by Application (2027-2033) & (US$ Million)

Table 19： North America Classical Swine Fever Vaccines Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 20： North America Classical Swine Fever Vaccines Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 21： Key Classical Swine Fever Vaccines Players in Europe

Table 22： Europe Classical Swine Fever Vaccines Revenue by Type (2021-2026) & (US$ Million)

Table 23： Europe Classical Swine Fever Vaccines Revenue by Type (2027-2033) & (US$ Million)

Table 24： Europe Classical Swine Fever Vaccines Revenue by Application (2021-2026) & (US$ Million)

Table 25： Europe Classical Swine Fever Vaccines Revenue by Application (2027-2033) & (US$ Million)

Table 26： Europe Classical Swine Fever Vaccines Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 27： Europe Classical Swine Fever Vaccines Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 28： Key Classical Swine Fever Vaccines Players in China

Table 29： China Classical Swine Fever Vaccines Revenue by Type (2021-2026) & (US$ Million)

Table 30： China Classical Swine Fever Vaccines Revenue by Type (2027-2033) & (US$ Million)

Table 31： China Classical Swine Fever Vaccines Revenue by Application (2021-2026) & (US$ Million)

Table 32： China Classical Swine Fever Vaccines Revenue by Application (2027-2033) & (US$ Million)

Table 33： Key Classical Swine Fever Vaccines Players in APAC (excl. China)

Table 34： APAC (excl. China) Classical Swine Fever Vaccines Revenue by Type (2021-2026) & (US$ Million)

Table 35： APAC (excl. China) Classical Swine Fever Vaccines Revenue by Type (2027-2033) & (US$ Million)

Table 36： APAC (excl. China) Classical Swine Fever Vaccines Revenue by Application (2021-2026) & (US$ Million)

Table 37： APAC (excl. China) Classical Swine Fever Vaccines Revenue by Application (2027-2033) & (US$ Million)

Table 38： APAC (excl. China) Classical Swine Fever Vaccines Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 39： APAC (excl. China) Classical Swine Fever Vaccines Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 40： Key Classical Swine Fever Vaccines Players in Latin America

Table 41： Latin America Classical Swine Fever Vaccines Revenue by Type (2021-2026) & (US$ Million)

Table 42： Latin America Classical Swine Fever Vaccines Revenue by Type (2027-2033) & (US$ Million)

Table 43： Latin America Classical Swine Fever Vaccines Revenue by Application (2021-2026) & (US$ Million)

Table 44： Latin America Classical Swine Fever Vaccines Revenue by Application (2027-2033) & (US$ Million)

Table 45： Latin America Classical Swine Fever Vaccines Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 46： Latin America Classical Swine Fever Vaccines Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 47： Key Classical Swine Fever Vaccines Players in Middle East & Africa

Table 48： Middle East & Africa Classical Swine Fever Vaccines Revenue by Type (2021-2026) & (US$ Million)

Table 49： Middle East & Africa Classical Swine Fever Vaccines Revenue by Type (2027-2033) & (US$ Million)

Table 50： Middle East & Africa Classical Swine Fever Vaccines Revenue by Application (2021-2026) & (US$ Million)

Table 51： Middle East & Africa Classical Swine Fever Vaccines Revenue by Application (2027-2033) & (US$ Million)

Table 52： Middle East & Africa Classical Swine Fever Vaccines Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 53： Middle East & Africa Classical Swine Fever Vaccines Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 54： Global Classical Swine Fever Vaccines Market Revenue by Key Suppliers (2021-2026) & (US$ Million)

Table 55： Global Classical Swine Fever Vaccines Revenue Market Share by Key Suppliers (2021-2026)

Table 56： Global Key Suppliers Headquarter Location and Key Area Sales

Table 57： Market Mergers & Acquisitions, Expansion

Table 58： Winsun Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 59： Winsun Bio-Pharmaceutical Classical Swine Fever Vaccines Product Portfolio

Table 60： Winsun Bio-Pharmaceutical Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 61： MSD Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 62： MSD Animal Health Classical Swine Fever Vaccines Product Portfolio

Table 63： MSD Animal Health Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 64： CAHIC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 65： CAHIC Classical Swine Fever Vaccines Product Portfolio

Table 66： CAHIC Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 67： Tecon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 68： Tecon Classical Swine Fever Vaccines Product Portfolio

Table 69： Tecon Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 70： SPAH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 71： SPAH Classical Swine Fever Vaccines Product Portfolio

Table 72： SPAH Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 73： Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 74： Boehringer Ingelheim Classical Swine Fever Vaccines Product Portfolio

Table 75： Boehringer Ingelheim Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 76： Ceva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 77： Ceva Classical Swine Fever Vaccines Product Portfolio

Table 78： Ceva Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 79： Harbin Weike BIOTECHNOLOGY Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 80： Harbin Weike BIOTECHNOLOGY Classical Swine Fever Vaccines Product Portfolio

Table 81： Harbin Weike BIOTECHNOLOGY Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 82： Qilu Animal Health Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 83： Qilu Animal Health Products Classical Swine Fever Vaccines Product Portfolio

Table 84： Qilu Animal Health Products Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 85： Ringpu Bio-Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 86： Ringpu Bio-Technology Classical Swine Fever Vaccines Product Portfolio

Table 87： Ringpu Bio-Technology Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 88： DaHuaNong Animal Health Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 89： DaHuaNong Animal Health Products Classical Swine Fever Vaccines Product Portfolio

Table 90： DaHuaNong Animal Health Products Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 91： CAVAC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 92： CAVAC Classical Swine Fever Vaccines Product Portfolio

Table 93： CAVAC Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 94： Komipharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 95： Komipharm Classical Swine Fever Vaccines Product Portfolio

Table 96： Komipharm Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 97： Agrovet Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 98： Agrovet Classical Swine Fever Vaccines Product Portfolio

Table 99： Agrovet Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 100： Bioveta Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 101： Bioveta Classical Swine Fever Vaccines Product Portfolio

Table 102： Bioveta Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 103： Jinyu Bio-Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 104： Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio

Table 105： Jinyu Bio-Technology Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 106： Institutul Pasteur Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 107： Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio

Table 108： Institutul Pasteur Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 109： MVP Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 110： MVP Classical Swine Fever Vaccines Product Portfolio

Table 111： MVP Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 112： Classical Swine Fever Vaccines Typical Customer List

Table 113： Classical Swine Fever Vaccines Distributors List

Figure 1： Classical Swine Fever Vaccines Product Pictures

Figure 2： C-Strain Live Attenuated Vaccine Picture Scope

Figure 3： Thiverval Strain Vaccine Picture Scope

Figure 4： Others Picture Scope

Figure 5： Government Tender Picture Scope

Figure 6： Market Sales Picture Scope

Figure 7： Global Classical Swine Fever Vaccines Market Size Analysis: 2025 VS 2026 VS 2033 (US$ Million)

Figure 8： Global Classical Swine Fever Vaccines Market Revenue and Growth Rate Analysis: (2021-2033) & (US$ Million)

Figure 9： Global Classical Swine Fever Vaccines Market Size by Region (2021-2033) & (US$ Million)

Figure 10： Global Classical Swine Fever Vaccines Market Share Scenario by Region in Percentage: 2026 Versus 2033

Figure 11： North America Classical Swine Fever Vaccines Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 12： North America Classical Swine Fever Vaccines Market Share by Players in 2025

Figure 13： North America Classical Swine Fever Vaccines Revenue Market Share by Type (2021-2033)

Figure 14： North America Classical Swine Fever Vaccines Revenue Market Share by Application (2021-2033)

Figure 15： US Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 16： Canada Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 17： Europe Classical Swine Fever Vaccines Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 18： Europe Classical Swine Fever Vaccines Market Share by Players in 2025

Figure 19： Europe Classical Swine Fever Vaccines Revenue Market Share by Type (2021-2033)

Figure 20： Europe Classical Swine Fever Vaccines Revenue Market Share by Application (2021-2033)

Figure 21： Germany Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 22： France Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 23： United Kingdom Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 24： Italy Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 25： Spain Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 26： Benelux Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 27： China Classical Swine Fever Vaccines Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 28： China Classical Swine Fever Vaccines Market Share by Players in 2025

Figure 29： China Classical Swine Fever Vaccines Revenue Market Share by Type (2021-2033)

Figure 30： China Classical Swine Fever Vaccines Revenue Market Share by Application (2021-2033)

Figure 31： APAC (excl. China) Classical Swine Fever Vaccines Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 32： APAC (excl. China) Classical Swine Fever Vaccines Market Share by Players in 2025

Figure 33： APAC (excl. China) Classical Swine Fever Vaccines Revenue Market Share by Type (2021-2033)

Figure 34： APAC (excl. China) Classical Swine Fever Vaccines Revenue Market Share by Application (2021-2033)

Figure 35： Japan Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 36： South Korea Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 37： India Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 38： Australia Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 39： Southeast Asia Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 40： Latin America Classical Swine Fever Vaccines Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 41： Latin America Classical Swine Fever Vaccines Market Share by Players in 2025

Figure 42： Latin America Classical Swine Fever Vaccines Revenue Market Share by Type (2021-2033)

Figure 43： Latin America Classical Swine Fever Vaccines Revenue Market Share by Application (2021-2033)

Figure 44： Mexico Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 45： Brazil Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 46： Middle East & Africa Classical Swine Fever Vaccines Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 47： Middle East & Africa Classical Swine Fever Vaccines Market Share by Players in 2025

Figure 48： Middle East & Africa Classical Swine Fever Vaccines Revenue Market Share by Type (2021-2033)

Figure 49： Middle East & Africa Classical Swine Fever Vaccines Revenue Market Share by Application (2021-2033)

Figure 50： Saudi Arabia Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 51： South Africa Classical Swine Fever Vaccines Revenue (2021-2033) & (US$ Million)

Figure 52： Global Classical Swine Fever Vaccines Revenue Market Share by Key Suppliers in 2025

Figure 53： Global Classical Swine Fever Vaccines Industry Competition Landscape

Figure 54： Classical Swine Fever Vaccines Industry Chain Analysis

Figure 55： Bottom-Up and Top-Down Research Methods

Figure 56： Key Interview Objectives

Figure 57： Data Cross Validation